Literature DB >> 14325294

MICROBIOLOGICAL ACTIVITIES OF LYSOSTAPHIN AND PENICILLINS AGAINST BACTERIOPHAGE 80/81 STRAINS OF STAPHYLOCOCCUS AUREUS.

W A ZYGMUNT, E F HARRISON, H P BROWDER.   

Abstract

Using 20 clinical isolates of S. aureus (all bacteriophage 80/81 type), we found that lysostaphin inhibits the growth of all cultures at concentrations significantly lower than those observed with any of eight penicillins, a penicillin-like compound (cephalothin), or fusidic acid (a steroid antibiotic). All test cultures were shown to be resistant to penicillin G, ampicillin, and propicillin. Of the remaining penicillins (all penicillinase-insensitive), oxacillin, nafcillin, cloxacillin, and cephalothin were approximately equal in antimicrobial activity. Ancillin was slightly less active, and methicillin was even lower in potency. Cultures varied more widely in susceptibility to fusidic acid. None of the clinical isolates tested was found to be resistant to lysostaphin.

Entities:  

Keywords:  ANTIBIOTICS; BACTERIOPHAGE TYPING; CEPHALOTHIN; DRUG RESISTANCE, MICROBIAL; EXPERIMENTAL LAB STUDY; FUSIDIC ACID; LYSOSTAPHIN; PENICILLIN; PENICILLINASE; STAPHYLOCOCCAL PHAGES; STAPHYLOCOCCUS

Mesh:

Substances:

Year:  1965        PMID: 14325294      PMCID: PMC1058278          DOI: 10.1128/am.13.3.491-493.1965

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  8 in total

1.  LYSOSTAPHIN THERAPY IN MICE INFECTED WITH STAPHYLOCOCCUS AUREUS.

Authors:  V T SCHUHARDT; C A SCHINDLER
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

2.  LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS.

Authors:  C A SCHINDLER; V T SCHUHARDT
Journal:  Proc Natl Acad Sci U S A       Date:  1964-03       Impact factor: 11.205

3.  THE NEW PENICILLINS.

Authors:  J O KLEIN; M FINLAND
Journal:  N Engl J Med       Date:  1963-11-14       Impact factor: 91.245

4.  THE IN VITRO EFFECT OF LYSOSTAPHIN ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS.

Authors:  C B CROPP; E F HARRISON
Journal:  Can J Microbiol       Date:  1964-12       Impact factor: 2.419

5.  PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS.

Authors:  C A SCHINDLER; V T SCHUHARDT
Journal:  Biochim Biophys Acta       Date:  1965-02-15

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Modified Gots test for penicillinase production.

Authors:  T H HAIGHT; M FINLAND
Journal:  Am J Clin Pathol       Date:  1952-08       Impact factor: 2.493

8.  COMPARATIVE IN VITRO ACTIVITIES OF LYSOSTAPHIN AND OTHER ANTISTAPHYLOCOCCAL ANTIBIOTICS ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS.

Authors:  E F HARRISON; C B CROPP
Journal:  Appl Microbiol       Date:  1965-03
  8 in total
  6 in total

1.  [Studies with lysotaphin. II. Lysostaphin sensitivity of 230 strains of Staph. aureus of animal origin].

Authors:  G Pulverer
Journal:  Z Med Mikrobiol Immunol       Date:  1968

2.  Lysostaphin in experimental renal infections.

Authors:  E F Harrison; W A Zygmunt
Journal:  J Bacteriol       Date:  1967-02       Impact factor: 3.490

3.  Direct diazo-transfer reaction on beta-lactam: synthesis and preliminary biological activities of 6-triazolylpenicillanic acids.

Authors:  Po C Chen; Rebekah E Wharton; Pratiq A Patel; Adegboyega K Oyelere
Journal:  Bioorg Med Chem       Date:  2007-08-25       Impact factor: 3.641

4.  Comparative inhibition of methicillin-resistant strains of Staphylococcus aureus by lysostaphin and other antibiotics.

Authors:  W A Zygmunt; E F Harrison; H P Browder; P A Tavormina
Journal:  Appl Microbiol       Date:  1968-08

5.  Influence of blood and serum on the antistaphylococcal activity of lysostaphin.

Authors:  W A Sygmunt; H P Browder; P A Tavormina
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

Review 6.  Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.

Authors:  Maria do Carmo de Freire Bastos; Bruna Gonçalves Coutinho; Marcus Lívio Varella Coelho
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.